PHASE II/III STUDY EVALUATING THE EFFECT OF IL-2 ON PRESERVATION OF THE CD4 T-LYMPHOCYTES AFTER INTERRUPTION OF ANTIRETROVIRAL TREATMENT IN HIV-INFECTED PATIENTS WITH CD4 T-LYMPHOCYTE COUNT GREATER THAN 500 CELLS/MM3 WHO RECEIVED ANTIRETROVIRAL TX: